Phase I Study of Oncolytic Vaccinia Virus GL-ONC1 in Patients with Peritoneal Carcinomatosis

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Ulrich M LauerNisar P Malek

Abstract

Purpose: Peritoneal carcinomatosis is common in advanced tumor stages or disease recurrence arising from gastrointestinal cancers, gynecologic malignancies, or primary peritoneal carcinoma. Because current therapies are mostly ineffective, new therapeutic approaches are needed. Here, we report on a phase I study designed to assess safety, MTD, and antitumor activity of intraperitoneal administration of oncolytic vaccinia virus GL-ONC1 in advanced stage peritoneal carcinomatosis patients.Patients and Methods: GL-ONC1 was administered intraperitoneally every 4 weeks for up to four cycles at three different dose levels (107-109 pfu) following a standard 3+3 dose escalation design. GL-ONC1 was infused via an indwelling catheter that enabled repetitive analyses of peritoneal fluid biopsies. The primary study objective was safety of GL-ONC1 according to Common Terminology Criteria for Adverse Events, version 4.0 (CTCAEv4.0).Results: Patients with advanced-stage peritoneal carcinomatosis (n = 7) or advanced peritoneal mesothelioma (n = 2) received 24 doses of GL-ONC1. Adverse events were limited to grades 1-3, including transient flu-like symptoms and increased abdominal pain, resulting from treatment-induced peritonitis. No DLT was r...Continue Reading

References

Sep 1, 1988·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·B A RunyonT R Morgan
Dec 6, 2002·The Journal of General Virology·Geoffrey L SmithMansun Law
Mar 1, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·O GlehenF N Gilly
Oct 11, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Vic J VerwaalFrans A N Zoetmulder
Dec 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrew L FeldmanH Richard Alexander
Mar 16, 2004·Virology·Clare E BlueDavid J Blackbourn
Jul 14, 2004·Proceedings of the National Academy of Sciences of the United States of America·Stephen C HarrisonJulie Theriot
Dec 21, 2005·Virology·Bernard Moss
Dec 13, 2006·The Journal of Allergy and Clinical Immunology·Janie Parrino, Barney S Graham
Jun 19, 2007·Trends in Pharmacological Sciences·Stephen J Russell, Kah-Whye Peng
Nov 16, 2007·Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen·D Arnold, F Lordick
May 18, 2010·International Journal of Cancer. Journal International Du Cancer·Markus M HeissSimon L Parsons
Oct 13, 2011·Journal of Translational Medicine·Michael HessAladar A Szalay
Mar 13, 2012·Antiviral Research·Mark N Prichard, Earl R Kern
Jul 6, 2014·Nature Reviews. Cancer·Brian D LichtyJohn C Bell
Oct 9, 2014·Molecular Therapy : the Journal of the American Society of Gene Therapy·Herbert J ZehDavid L Bartlett
Mar 26, 2015·Molecular Therapy : the Journal of the American Society of Gene Therapy·Laura EvginJ Andrea McCart
Jun 16, 2015·Molecular Therapy : the Journal of the American Society of Gene Therapy·Se Hoon ParkYoung Suk Park
May 21, 2016·Molecular Therapy : the Journal of the American Society of Gene Therapy·Stephanie Downs-CannerDavid L Bartlett
Jan 24, 2017·The Cancer Journal·Praveen K BommareddyHoward L Kaufman
Jul 7, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Loren K MellAladar A Szalay

❮ Previous
Next ❯

Citations

Mar 29, 2019·Expert Opinion on Biological Therapy·Lino E Torres-Domínguez, Grant McFadden
Oct 31, 2019·Microbiology and Immunology·Maria TerrívelAna Miguel Matos
Jun 13, 2020·Cancers·Praveensingh B HajeriMasato Yamamoto
Aug 21, 2019·Journal of Translational Medicine·Boris R MinevAladar A Szalay
Sep 4, 2020·Science Translational Medicine·Anthony K ParkSaul J Priceman
Jan 11, 2019·Journal for Immunotherapy of Cancer·Zong Sheng GuoDavid L Bartlett
Oct 21, 2020·International Journal of Molecular Sciences·Susanne BerchtoldUlrich M Lauer
Aug 24, 2020·Current Problems in Cancer·Nasser Hashemi GoradelBabak Negahdari
Aug 17, 2020·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Abdolreza OsaliAbdolreza Esmaeilzadeh
Apr 10, 2021·Current Problems in Surgery·John H StewartKonstantinos I Votanopoulos
Apr 25, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Chen YangXiangmin Tong
Mar 20, 2021·Journal of Medical Virology·Weijian LinLiping Zhong
Apr 28, 2021·Translational Research : the Journal of Laboratory and Clinical Medicine·Noraini Abd-Aziz, Chit Laa Poh
Mar 31, 2021·FEMS Microbiology Reviews·Ana Mafalda PintoSanna Sillankorva
Jul 7, 2021·British Journal of Cancer·Joanna ObaczStefan J Marciniak

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.